Form 4: GE HealthCare Director H. Lawrence Culp Jr. Reports Stock Transaction
SEC Form 4
Director H. Lawrence Culp Jr. of GE HealthCare Technologies Inc. reports the withholding of shares to cover tax obligations related to vesting performance stock units.
Summary
- On March 1, 2024, H. Lawrence Culp Jr., a director of GE HealthCare Technologies Inc., reported a transaction involving the withholding of 31,290 shares of common stock to satisfy tax obligations.
- The shares were withheld in connection with the vesting of performance stock units previously reported on December 29, 2023.
- Following the transaction, Culp directly owns 621,634 shares of GE HealthCare common stock.
- Culp also indirectly owns 1,271 shares through family trusts and 70,402 shares through a holding company.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine transaction related to tax obligations. It doesn't indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax-related withholding of shares.
Key Dates
| Date | Description |
|---|---|
| 12/29/2023 | Date of previous Form 4 filing reporting performance stock units. |
| 03/01/2024 | Date of transaction: withholding of shares for tax obligations. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.